SCHEMBL25358982

SCHEMBL25358982

Cc1cc(C(C)Cl)c2nc(N3CCCCC3)cc(=O)n2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 14/20 0.60
AKT1 P31749 1/20 0.60
AKT2 P31751 1/20 0.60
AKT3 Q9Y243 1/20 0.60
PIK3CB P42338 19/20 0.53
PIK3CD O00329 8/20 0.53
PIK3CG P48736 3/20 0.53
PIK3R1 P27986 1/20 0.53
CSNK1A1 P48729 1/20 0.53
PTK2 Q05397 1/20 0.53
CLK4 Q9HAZ1 1/20 0.53
SRC P12931 1/20 0.48
DDX6 P26196 1/20 0.48
PDE4A P27815 1/20 0.48
CSK P41240 1/20 0.48
MTOR P42345 1/20 0.48
PLK1 P53350 1/20 0.48
PRKDC P78527 1/20 0.48
PDE4B Q07343 1/20 0.48
PDE4C Q08493 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27121826 0.89 PIK3CA (0.61) PIK3CAAKT1AKT2AKT3PIK3CB
SCHEMBL25358740 0.88 PIK3CA (0.60) PIK3CAAKT1AKT2AKT3PIK3CB
SCHEMBL25364344 0.88 PIK3CA (0.63) PIK3CAAKT1AKT2AKT3PIK3CB
SCHEMBL27122136 0.84 PIK3CA (0.45) PIK3CAAKT1AKT2AKT3PIK3CB
SCHEMBL32688088 0.83 PIK3CA (0.63) PIK3CAAKT1AKT2AKT3PIK3CB
SCHEMBL32688217 0.82 PIK3CA (0.57) PIK3CAAKT1AKT2AKT3PIK3CB
SCHEMBL27116444 0.81 PIK3CA (0.63) PIK3CAAKT1AKT2AKT3PIK3CB
SCHEMBL12700775 0.80 PIK3CB (0.82) PIK3CAAKT1AKT2AKT3PIK3CB
SCHEMBL27116502 0.80 PIK3CA (0.55) PIK3CAAKT1AKT2AKT3PIK3CB
SCHEMBL25360705 0.80 PIK3CA (0.51) PIK3CAAKT1AKT2AKT3PIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023159155-A1 INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) AND USES THEREOF PIVALENT THERAPEUTICS, INC. (US) 2023-08-24 WO disclosed